RYR & Nattokinase III
Natural health product licensed in Canada
- Other names
- NattoRYR, Nattokinase RED, RED NATTOkinase, RYR & Nattokinase, RYR + Nattokinase, Red Yeast Rice & Nattokinase
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80095272
- Status
- Active licence
- Licence date
- 7 November 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Oryza sativa fermenté avec Monascus purpurea Source : Monascus purpureus (En entier) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,100 mg Potency : 1 % Ankaflavin | 110 mg | Not calculated |
| Nattokinase Source : Bacillus subtilis var. natto - Whole | 100 mg | Not calculated |
| Nattokinase Source : Glycine max - Graine | 100 mg | Not calculated |
| Oryza sativa fermenté avec Monascus purpurea Source : Monascus purpureus (En entier) Potency : 3 % Monascin | 2,800 FU | Not calculated |
Non-medicinal ingredients
Maltodextrine, bêta Cyclodextrin, Palmitate d'ascorbyle, Stéaryl fumarate de sodium, Dioxyde de silicium, Cellulose microcristalline, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Nattokinase helps to support cardiovascular system health. Red yeast rice provides antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
This product is derived from soy. Do not use if you have soy allergy.
- Précautions et mises en garde
Consult a qualified health practitioner prior to use if you are taking other medication, particularly cyclosporine, blood thinners, blood lipid lowering medications, blood pressure medications or anti-diabetic drugs, or suffer from liver or kidney disease or have received an organ transplant. If you experience muscle pain, tenderness and/ or weakness, discontinue use and consult a health care practitioner. Consult a health care practitioner if you have a cardiovascular, kidney, or liver disorder, or if you are taking any medications. Stop using these products 7 days before any scheduled surgery, or immediately if you have unscheduled surgery or if you suffer from an injury resulting in bruising or bleeding.
- Contre-indications
Do not use if you are pregnant or plan to become pregnant or are breastfeeding. Do not use this product if you are taking health products that affect blood coagulation or if you have a bleeding disorder.
Source
Official Health Canada record, licence 80095272
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.